161 related articles for article (PubMed ID: 38263817)
1. Prediction of pathological complete response of breast cancer patients who received neoadjuvant chemotherapy with a nomogram based on clinicopathologic variables, ultrasound, and MRI.
Zhang MQ; Liu XP; Du Y; Zha HL; Zha XM; Wang J; Liu XA; Wang SJ; Zou QG; Zhang JL; Li CY
Br J Radiol; 2024 Jan; 97(1153):228-236. PubMed ID: 38263817
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram.
Kim SY; Cho N; Choi Y; Lee SH; Ha SM; Kim ES; Chang JM; Moon WK
Radiology; 2021 May; 299(2):290-300. PubMed ID: 33754824
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Dynamic Contrast-enhanced and Diffusion-weighted MRI.
Zhao R; Lu H; Li YB; Shao ZZ; Ma WJ; Liu PF
Acad Radiol; 2022 Jan; 29 Suppl 1():S155-S163. PubMed ID: 33593702
[TBL] [Abstract][Full Text] [Related]
6. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer.
Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y
Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646
[TBL] [Abstract][Full Text] [Related]
7. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer.
Vila J; Mittendorf EA; Farante G; Bassett RL; Veronesi P; Galimberti V; Peradze N; Stauder MC; Chavez-MacGregor M; Litton JF; Huo L; Kuerer HM; Hunt KK; Caudle AS
Ann Surg Oncol; 2016 Oct; 23(11):3501-3509. PubMed ID: 27216742
[TBL] [Abstract][Full Text] [Related]
8. Nomogram for Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Combining Both Clinicopathological and Imaging Indicators.
Wang H; Lu Y; Li Y; Li S; Zhang X; Geng C
Curr Probl Cancer; 2022 Dec; 46(6):100914. PubMed ID: 36351312
[TBL] [Abstract][Full Text] [Related]
9. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
[TBL] [Abstract][Full Text] [Related]
10. Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy.
Wang W; Wang X; Liu J; Zhu Q; Wang X; Wang P
Chin Med J (Engl); 2021 Dec; 135(3):333-340. PubMed ID: 35108228
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Nomogram for Individually Predicting Pathologic Complete Remission After Preoperative Chemotherapy in Chinese Breast Cancer: A Population-Based Study.
Hou N; Xiao J; Wang Z; Wu Y; Hou G; Guo L; Zhang J; Ling R
Clin Breast Cancer; 2020 Dec; 20(6):e682-e694. PubMed ID: 32713825
[TBL] [Abstract][Full Text] [Related]
12. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.
Kim R; Chang JM; Lee HB; Lee SH; Kim SY; Kim ES; Cho N; Moon WK
Radiology; 2019 Oct; 293(1):49-57. PubMed ID: 31407967
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI-based radiomics nomogram for early prediction of pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Li J; Yin H; Wang Y; Zhang H; Ma F; Li H; Qu J
Eur Radiol; 2023 Apr; 33(4):2746-2756. PubMed ID: 36512039
[TBL] [Abstract][Full Text] [Related]
14. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
[No Abstract] [Full Text] [Related]
15. A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy.
Ma R; Wei W; Ye H; Dang C; Li K; Yuan D
BMC Cancer; 2023 Mar; 23(1):245. PubMed ID: 36918796
[TBL] [Abstract][Full Text] [Related]
16. A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
Guo R; Su Y; Si J; Xue J; Yang B; Zhang Q; Chi W; Chen J; Chi Y; Shao Z; Wu J
Cancer; 2020 Aug; 126 Suppl 16():3819-3829. PubMed ID: 32710664
[TBL] [Abstract][Full Text] [Related]
17. Imaging and Clinicopathologic Features Associated With Pathologic Complete Response in HER2-positive Breast Cancer Receiving Neoadjuvant Chemotherapy With Dual HER2 Blockade.
Yoon GY; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH; Kim JE; Kim SB
Clin Breast Cancer; 2020 Feb; 20(1):25-32. PubMed ID: 31519449
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound Strain Elastography and Contrast-Enhanced Ultrasound in Predicting the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: A Nomogram Integrating Ki-67 and Ultrasound Features.
Liu Q; Tang L; Chen M
J Ultrasound Med; 2022 Sep; 41(9):2191-2201. PubMed ID: 34888900
[TBL] [Abstract][Full Text] [Related]
19. A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.
Hwang HW; Jung H; Hyeon J; Park YH; Ahn JS; Im YH; Nam SJ; Kim SW; Lee JE; Yu JH; Lee SK; Choi M; Cho SY; Cho EY
Breast Cancer Res Treat; 2019 Jan; 173(2):255-266. PubMed ID: 30324273
[TBL] [Abstract][Full Text] [Related]
20. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.
Shi Z; Huang X; Cheng Z; Xu Z; Lin H; Liu C; Chen X; Liu C; Liang C; Lu C; Cui Y; Han C; Qu J; Shen J; Liu Z
Radiology; 2023 Jul; 308(1):e222830. PubMed ID: 37432083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]